Safety of guselkumab in Inflammatory Bowel Disease up to 1 year: Integrated safety analysis of phase 2 and 3 studies in Crohn's Disease and Ulcerative Colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Panaccione, R. [2 ]
Danese, S. [3 ,4 ]
Panes, J. [4 ,5 ]
Hisamatsu, T. [5 ,6 ]
D'Haens, G. [6 ,7 ]
Van Rampelbergh, R. [7 ,8 ]
Olurinde, M. [8 ,9 ]
Yee, J. [8 ,9 ]
Baker, T. [8 ,9 ]
Yarandi, S. [8 ,9 ]
Germinaro, M. [8 ,9 ]
Vetter, M. L. [8 ,9 ]
Li, H. [8 ,9 ]
Ballina, M. Rosas [9 ,10 ]
Allegretti, J. [10 ,11 ,12 ]
Afzali, A. [12 ,13 ]
Rubin, D. T. [13 ]
机构：
[1] Ichan Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY USA
[2] Univ Calgary, Div Gastroenterol, Inflammatory Bowel Dis Unit, Calgary, AB, Canada
[3] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[4] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[5] Hosp Clin Barcelona, IDIBAPS CIBERehd, Barcelona, Spain
[6] Kyorin Univ, Sch Med, Med Ctr, Tokyo, Japan
[7] Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[8] Janssen Res & Dev, Immunol, Antwerp, Belgium
[9] Janssen Res & Dev, Immunol, Spring House, PA USA
[10] Actelion Res & Dev, Immunol, Allschwil, Switzerland
[11] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[12] Harvard Med Sch, Div Gastroenterol Hepatol & endoscopy, Boston, MA USA
[13] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0782
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0608
引用
收藏
页码：i1206 / i1208
页数：3
相关论文
共 50 条
  • [1] Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    O'Brien, Christopher D.
    Ott, Elyssa
    Marano, Colleen
    Zhou, Yiying
    Volger, Sheri
    Tikhonov, Ilia
    Gasink, Christopher
    Danese, Silvio
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S408 - S409
  • [2] Integrated Safety Analysis of Vedolizumab for the Treatment of Ulcerative Colitis or Crohn's Disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Feagan, Brian G.
    Loftus, Edward V.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    GASTROENTEROLOGY, 2013, 144 (05) : S113 - S113
  • [3] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
    Ghosh, Subrata
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Godwin, Bridget
    Marano, Colleen
    Miao, Ye
    Ma, Tony
    Loftus, Edward, V
    Sandborn, William J.
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1091 - 1101
  • [4] The safety of vedolizumab for ulcerative colitis and Crohn's disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Sandborn, William
    Danese, Silvio
    D'Haens, Geert
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    Abhyankar, Brihad
    Feagan, Brian G.
    GUT, 2017, 66 (05) : 839 - 851
  • [5] Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis
    Hagan, Matilda
    Cross, Raymond K.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (09) : 1473 - 1479
  • [6] Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn's disease (CD) and 2 years in ulcerative colitis (UC)
    Ghosh, Subrata
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Colombel, Jean-Frederic
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 107 - 107
  • [7] Analysis of integrated inflammatory bowel disease mouse models to assess their disease driving pathways and relevance for Crohn's disease and Ulcerative colitis
    Schultz, Weiwei
    Monast, Calixte
    Hesse, Mathias
    Chang, Leon
    Scully, Michael
    Chen, Yanqing
    Liu, Xuejun
    Hutchins, Zachary
    Pavlidis, Stelios
    Baribaud, Frederic
    PROCEEDINGS 2018 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2018, : 2806 - 2807
  • [8] Inflammatory bowel diseases. Crohn's disease and ulcerative colitis
    Fischer, S.
    Rath, T.
    Neurath, M. F.
    INTERNIST, 2018, 59 (07): : 681 - 692
  • [9] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
    Sandborn, William J.
    Feagan, Brian G.
    Danese, Silvio
    O'Brien, Christopher D.
    Ott, Elyssa
    Marano, Colleen
    Baker, Thomas
    Zhou, Yiying
    Volger, Sheri
    Tikhonov, Ilia
    Gasink, Christopher
    Sands, Bruce E.
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) : 994 - 1007
  • [10] Effect of Obesity on Inflammatory Bowel Disease (Ulcerative Colitis vs Crohn's Disease)
    Dasu, Neethi
    Khalid, Yaser
    Blair, Brian
    Walters, Richard
    Chhoun, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S678 - S679
12345